Physician

Shelley Denise Jones, M.D.

According to 2025 Medicare claims, Shelley Jones, M.D. (NPI: 1598752800) practices infectious disease in the Wichita, KS market, with the plurality of this provider's patient population coming from Sedgwick, KS. This provider's primary affiliated billing organization is INFECTIOUS DISEASE CONSULTANTS, P.A. (NPI: 1306830641; TIN: 480894464) and primary practice location at 67211-2129. Jones is affiliated with the Aledade 155 National MSSP (ACO ID: A5358), participating under the MSSP model.

Jones' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 812 traditional Medicare patients, billed 124,624 HCPCS/CPT codes, and received $994,005 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,028 prescription claims across 241 beneficiaries totaling $345,768 in drug costs, led by Daptomycin (Daptomycin). DME data shows 64 claims. Open Payments data shows 21 records totaling $408. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $153,828 to $994,005. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $435,308 and ending at $345,768. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $416 and ending at $980.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	466	10,346	$153,828
2016	604	6,488	$197,547
2017	720	10,200	$281,804
2018	819	26,761	$389,254
2019	893	21,490	$382,680
2020	911	36,625	$634,934
2021	835	81,506	$613,692
2022	772	50,588	$505,478
2023	823	61,451	$753,037
2024	812	124,624	$994,005

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	79	648	$435,308
2016	101	358	$371,007
2017	119	522	$272,059
2018	146	706	$267,373
2019	198	926	$571,136
2020	167	913	$353,086
2021	166	931	$242,821
2022	186	964	$304,735
2023	194	894	$515,938
2024	241	1,028	$345,768

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	35	$7,173
2017	N/R	48	$6,400
2018	N/R	46	$5,969
2019	N/R	45	$6,556
2020	N/R	36	$7,108
2021	N/R	34	$7,554
2022	N/R	30	$6,608
2023	N/R	54	$9,181
2024	N/R	64	$41,103

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	436	523	$127
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	311	988	$87
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	128	178	$84
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	446	1,427	$58
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	145	510	$44

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Daptomycin	Daptomycin	74	505	$115,509
Symtuza	Darunavir/Cob/Emtri/Tenof Alaf	12	360	$64,694
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	12	360	$44,908
Tivicay	Dolutegravir Sodium	12	360	$31,126
Ertapenem	Ertapenem Sodium	44	294	$25,921

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	22	$40,123
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	22	$882
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	20	$98

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$408	Paratek Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shelley Denise Jones, M.D.?

Tedicare shows public-source Medicare data for Shelley Denise Jones, M.D. (NPI 1598752800), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shelley Denise Jones, M.D. have ACO affiliation data?

Shelley Denise Jones, M.D. is shown with ACO affiliation data for Aledade 155 National MSSP (MSSP, ACO ID A5358).

What billing organization is linked to Shelley Denise Jones, M.D.?

Shelley Denise Jones, M.D. is linked to INFECTIOUS DISEASE CONSULTANTS, P.A. (billing NPI 1306830641) in the available physician profile data.

Does Shelley Denise Jones, M.D. have Open Payments data?

Shelley Denise Jones, M.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.